Form 4: Corcept Therapeutics President Sells Shares
Insider Transaction (Form 4)
Roberto Wandenkolk Vieira, President, Oncology of Corcept Therapeutics Inc, sold 296 shares of common stock on September 16, 2026 for $100.82 per share.
Summary
- Open-market sale: disposed of 296 Common Stock at $100.82 ($29,843) on September 16, 2026; holds 3,946 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $29,843 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Roberto Wandenkolk Vieira — Officer (President, Oncology)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Open-market sale | Common Stock | 296 | $101 | $29.8K | 3,946 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Open-market sale (296 shares) |
Keywords
insider transaction, Form 4, CORT, CORCEPT THERAPEUTICS INC, bearish, Roberto Wandenkolk Vieira
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.